192 related articles for article (PubMed ID: 18508558)
1. Arterial remodeling in vascular disease: a key role for hyaluronan and versican.
Wight TN
Front Biosci; 2008 May; 13():4933-7. PubMed ID: 18508558
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.
Evanko SP; Johnson PY; Braun KR; Underhill CB; Dudhia J; Wight TN
Arch Biochem Biophys; 2001 Oct; 394(1):29-38. PubMed ID: 11566024
[TBL] [Abstract][Full Text] [Related]
3. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
Evanko SP; Angello JC; Wight TN
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1004-13. PubMed ID: 10195929
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
[TBL] [Abstract][Full Text] [Related]
5. Provisional matrix: A role for versican and hyaluronan.
Wight TN
Matrix Biol; 2017 Jul; 60-61():38-56. PubMed ID: 27932299
[TBL] [Abstract][Full Text] [Related]
6. Proteoglycans in atherosclerosis and restenosis: key roles for versican.
Wight TN; Merrilees MJ
Circ Res; 2004 May; 94(9):1158-67. PubMed ID: 15142969
[TBL] [Abstract][Full Text] [Related]
7. Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.
Wight TN; Kang I; Evanko SP; Harten IA; Chang MY; Pearce OMT; Allen CE; Frevert CW
Front Immunol; 2020; 11():512. PubMed ID: 32265939
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.
Lemire JM; Merrilees MJ; Braun KR; Wight TN
J Cell Physiol; 2002 Jan; 190(1):38-45. PubMed ID: 11807809
[TBL] [Abstract][Full Text] [Related]
9. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
Schönherr E; Kinsella MG; Wight TN
Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM.
Gouëffic Y; Potter-Perigo S; Chan CK; Johnson PY; Braun K; Evanko SP; Wight TN
Atherosclerosis; 2007 Nov; 195(1):23-30. PubMed ID: 17174314
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk Between T Lymphocytes and Lung Fibroblasts: Generation of a Hyaluronan-Enriched Extracellular Matrix Adhesive for Monocytes.
Gaucherand L; Falk BA; Evanko SP; Workman G; Chan CK; Wight TN
J Cell Biochem; 2017 Aug; 118(8):2118-2130. PubMed ID: 27982477
[TBL] [Abstract][Full Text] [Related]
12. Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells.
Ogawa H; Oohashi T; Sata M; Bekku Y; Hirohata S; Nakamura K; Yonezawa T; Kusachi S; Shiratori Y; Ninomiya Y
Matrix Biol; 2004 Aug; 23(5):287-98. PubMed ID: 15464361
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.
Evanko SP; Potter-Perigo S; Bollyky PL; Nepom GT; Wight TN
Matrix Biol; 2012 Mar; 31(2):90-100. PubMed ID: 22155153
[TBL] [Abstract][Full Text] [Related]
14. Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion.
Kang I; Yoon DW; Braun KR; Wight TN
J Biol Chem; 2014 May; 289(22):15393-404. PubMed ID: 24719328
[TBL] [Abstract][Full Text] [Related]
15. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration.
Ström A; Olin AI; Aspberg A; Hultgårdh-Nilsson A
Cardiovasc Res; 2006 Feb; 69(3):755-63. PubMed ID: 16409997
[TBL] [Abstract][Full Text] [Related]
16. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.
Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A
Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury.
Huang R; Merrilees MJ; Braun K; Beaumont B; Lemire J; Clowes AW; Hinek A; Wight TN
Circ Res; 2006 Feb; 98(3):370-7. PubMed ID: 16385080
[TBL] [Abstract][Full Text] [Related]
18. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion.
Kolodgie FD; Burke AP; Farb A; Weber DK; Kutys R; Wight TN; Virmani R
Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1642-8. PubMed ID: 12377743
[TBL] [Abstract][Full Text] [Related]
19. Host stromal versican is essential for cancer-associated fibroblast function to inhibit cancer growth.
Fanhchaksai K; Okada F; Nagai N; Pothacharoen P; Kongtawelert P; Hatano S; Makino S; Nakamura T; Watanabe H
Int J Cancer; 2016 Feb; 138(3):630-41. PubMed ID: 26270355
[TBL] [Abstract][Full Text] [Related]
20. A role for versican in the development of leiomyosarcoma.
Keire PA; Bressler SL; Lemire JM; Edris B; Rubin BP; Rahmani M; McManus BM; van de Rijn M; Wight TN
J Biol Chem; 2014 Dec; 289(49):34089-103. PubMed ID: 25320080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
